The human polyomavirus, JCV, and neurological diseases (review).

Important note: Information in this article was accurate in 1999. The state of the art may have changed since the publication date.

The human polyomavirus, JCV, and neurological diseases (review).

Int J Mol Med. 1998 Apr;1(4):647-55. Unique Identifier : AIDSLINE MED/99074470
Gordon J; Khalili K; Center for NeuroVirology and NeuroOncology, Allegheny University; of the Health Sciences, Broad and Vine, MS 406, Philadelphia, PA; 19102, USA.

Abstract: JC virus, a human neurotropic polyomavirus, is the established etiologic agent of the fatal demyelinating disease, progressive multifocal leukoencephalopathy, which usually affects individuals with defects in cell-mediated immunity. Cytolytic destruction of oligodendrocytes, the myelin-producing cells of the central nervous system is attributed as the mechanism by which JCV induces demyelination. PML was at one time a rare complication however it is now a much more common disease affecting patients of all ages due to the prevalence of AIDS. Of interest, in vitro evidence points to a cooperative interaction between JCV and HIV-1, via the HIV-1 regulatory protein, Tat. In addition, JCV has been demonstrated to induce tumors of neural origin in several animal models, including rodents and non-human primates, and several clinical reports have suggested a possible association between JCV and glial-origin tumors in humans. The viral regulatory protein, T-antigen, which has been shown to play a key role in orchestrating the events of the viral lytic cycle, is also capable of altering cellular functions, by nature of its direct interaction with cellular regulatory proteins and by its effect on cellular transcription. In this review, we discuss clinical aspects of PML, the ability of JCV to induce tumors in animal models, and the ability of JCV T-antigen to alter cellular function in vitro.

Keywords: JOURNAL ARTICLE REVIEW REVIEW, TUTORIAL Animal AIDS-Related Opportunistic Infections/*VIROLOGY Central Nervous System Neoplasms/*VIROLOGY Human Leukoencephalopathy, Progressive Multifocal/DIAGNOSIS/*VIROLOGY Polyomavirus hominis 2/GROWTH & DEVELOPMENT/*GENETICS/ PATHOGENICITY Support, U.S. Gov't, P.H.S. Virus Activation
990530
A9950897

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1999. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1999. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .